Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Caplin Point Laboratories Ltd.

Caplin Point Lab

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
06 05 2021 Audited Results & Interim Dividend
05 08 2021 Quarterly Results & Final Dividend
02 11 2021 Quarterly Results
03 02 2022 Quarterly Results
12 05 2022 Audited Results & Interim Dividend
05 08 2022 Quarterly Results & Final Dividend
12 11 2022 Quarterly Results
11 02 2023 Quarterly Results
24 05 2023 Audited Results & Interim Dividend & Quarterly Results
27 05 2023 Audited Results (Revised) & Quarterly Results (Revised) & Interim Dividend
07 08 2023 Final Dividend & Quarterly Results & A.G.M.
09 11 2023 Quarterly Results
09 02 2024 Quarterly Results
07 11 2024 Quarterly Results
07 02 2025 Quarterly Results
15 05 2025 Interim Dividend & Audited Results
07 08 2025 A.G.M. & Quarterly Results & Final Dividend

News

01-JUN-2023

USFDA completes inspection at Sterile Injectable site of Caplin Point Laboratories’ arm

At the end of the inspection, there were four observations by US FDA

11:53 AM
02-APR-2025

Caplin Point Laboratories’ arm acquires Neoethicals Chile SpA

The Caplin Point Far East’s board had approved the investment in Neoethicals Chile SpA through the purchase of all its shares

05:05 PM
03-AUG-2023

Caplin Point Laboratories’ arm gets approval for incorporate wholly owned subsidiary in US

The Board of Directors of Caplin Steriles, at its meeting held on August 02, 2023, has approved the same

03:12 PM
03-MAR-2023

Caplin Point Laboratories’ arm gets USFDA’s approval for Rocuronium Bromide Injection

Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation

12:39 PM
04-JUN-2025

Caplin Point Laboratories’ arm executes SPA to acquire entire stake in Triwin Pharma

Triwin Pharma’s object is to operate in Mexico in the Pharmaceutical Marketing and Distribution business

03:41 PM
04-SEP-2023

Caplin Point Laboratories’ arm gets EIR from USFDA for Chennai unit

The unit underwent an inspection from USFDA during May 22- May 31

12:42 PM
05-FEB-2025

Caplin Point’s arm gets USFDA’s approval for Procainamide Hydrochloride Injection

It restores normal heart rhythm by blocking abnormal electrical signals in the heart

12:20 PM
07-AUG-2023

Caplin Point Laboratories reports 21% rise in Q1 consolidated net profit

Total consolidated income of the company increased by 13.07% at Rs 407.36 crore for Q1FY24

03:12 PM
07-AUG-2025

Caplin Point Laboratories reports 23% rise in Q1 consolidated net profit

The consolidated total income of the company increased by 11.69% at Rs 533.36 crore for Q1FY26

03:36 PM
07-JAN-2025

Caplin Point Laboratories receives EIR from USFDA

The unannounced USFDA inspection was conducted between August 5, 2024 and August 9, 2024 and was concluded with Zero 483 observations

10:59 AM
08-JAN-2024

Caplin Point Laboratories’ arm gets USFDA’s final approval for Ofloxacin Otic Solution

Ofloxacin Otic Solution 0.3% had US sales of around $36 million for the 12-month period ending June 2023

12:41 PM
08-MAR-2023

Caplin Point Laboratories’ arm gets USFDA’s nod for Thiamine Hydrochloride Injection

Thiamine Hydrochloride Injection is effective in the treatment of Thiamine (Vitamin B1) deficiency or beriberi

02:47 PM
09-JAN-2024

Caplin Point along with arms to invest Rs 700 crore in Tamil Nadu

This investment will be made by Caplin Point Laboratories and its subsidiaries - Caplin Steriles and Caplin One Labs

11:11 AM
11-AUG-2023

Caplin Point Laboratories listed on Forbes Asia’s ‘200 Best Under a Billion’ for 2023

The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity

12:39 PM
12-JUN-2023

Caplin Point Laboratories’ arm gets USFDA’s approval for Cisatracurium Besylate Injection

Cisatracurium Besylate Injection USP had US sales of approximately $35 million for the 12- month period ending December 2022

03:18 PM
12-MAY-2023

Caplin Point Laboratories’ arm gets USFDA’s nod for Ketorolac Tromethamine Injection

Ketorolac Tromethamine Injection USP had US sales of around $53 million for the 12-month period ending December 2022

11:57 AM
14-FEB-2023

Caplin Point Laboratories’ arm gets USFDA’s final approval for Carboprost Tromethamine Injection

Carboprost Tromethamine Injection USP is an oxytocic, indicated for the treatment of postpartum hemorrhage due to uterine atony

01:06 PM
14-MAY-2025

Caplin Point’s arm gets USFDA’s final nod for Haloperidol Decanoate Injection

Haloperidol Decanoate Injection had US sales of around $16.4 million for the 12- month period ending March 2025

02:28 PM
16-APR-2024

Caplin Point Laboratories’ arm gets final approval from USFDA for Ofloxacin Ophthalmic Solution

Ofloxacin Ophthalmic Solution USP 0.3% had US sales of around $52 million for the 12- month period ending December 2023

12:30 PM
16-DEC-2024

Caplin Point Laboratories’ arm gets USFDA’s approval for Difluprednate Ophthalmic Emulsion

Difluprednate Ophthalmic Emulsion, 0.5% had US sales of approximately $21 million for the 12-month period ending October 2024

12:48 PM
17-JAN-2025

Caplin Point’s arm gets USFDA’s approval for Levetiracetam in Sodium Chloride Injection, infusion bags

This is the second Ready-To-Use Infusion bag ANDA drug product approved for Caplin Steriles

02:28 PM
20-SEP-2023

Caplin Point Laboratories’ arm gets USFDA’s final approval for Norepinephrine Bitartrate Injection

Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients with acute hypotensive states

02:12 PM
22-AUG-2022

Caplin Point selected under Forbes Asia’s ‘200 best under billion list’

Forbes Asia has selected 200 best performing companies, with revenues of less than a billion

04:24 PM
23-APR-2025

Caplin Point Laboratories’ arm gets USFDA’s approval for Phytonadione Injectable Emulsion

Phytonadione Injectable Emulsion had US sales of around $18.5 million for the 12-month period ending February 2025

03:18 PM
27-FEB-2025

Caplin Point’s arm gets USFDA’s final nod for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution

Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution had US sales of around $242 million for the 12-month period ending December 2024

09:37 AM
27-MAR-2024

Caplin Point Laboratories’ arm completes new Oncology facility in Kakkalur

The facility will manufacture tablets, capsules, and injections, catering to the growing demand for high-quality pharmaceuticals in the oncology segment

11:30 AM
28-MAR-2024

Caplin Point Laboratories’ arm gets USFDA approval for Ketorolac tromethamine Ophthalmic Solution

Ketorolac tromethamine Ophthalmic Solution 0.5% had US sales of around $36 million for the 12-month period ending December 2023

11:12 AM
29-MAR-2023

Caplin Point to sell Caplin Point Laboratories Colombia SAS to Caplin Point Far East

Pursuant to execution of the Share Purchase Agreement and transfer of shares, Caplin Point Laboratories Colombia SAS - Colombia will cease to be a subsidiary of the Company

06:10 PM
Enrich money logo